Trials / Unknown
UnknownNCT04365322
Study of Specific Viral Immune Responses Induced by SARS-CoV-2 (COVID-19)
Étude Des réponses Immunitaires Lymphocytaires spécifiques Chez Des Patients infectés Par le Virus SARS-CoV-2 : Caractéristiques Des Réponses Effectrices et Mémoires
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 160 (estimated)
- Sponsor
- Centre Hospitalier Universitaire de Besancon · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
SARS-CoV-2, has caused an international outbreak of respiratory illness termed Covid-19. The investigators used peptides derived from SARS-CoV-2 virus, to study viral-specific immune responses. COV-CREM is a French prospective monocentric study that will evaluate viral-specific cell responses in positive patients for SARS-CoV-2 on the basis of (RT-PCR) assay performed in respiratory tract sample tested by our local Center for Disease Control.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Additional biological samples | Peripheral Blood Mononuclear Cell (PBMC) and plasma will be collected. |
Timeline
- Start date
- 2020-04-20
- Primary completion
- 2020-09-01
- Completion
- 2025-04-20
- First posted
- 2020-04-28
- Last updated
- 2020-07-14
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04365322. Inclusion in this directory is not an endorsement.